The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Adrenocortical Carcinoma: Diagnosis, Evaluation and Treatment
Abstract
PURPOSE: We describe the presenting features, imaging methods, prognosis of and treatment approach to adrenocortical carcinoma. MATERIALS AND METHODS: A comprehensive literature review of adrenal carcinoma was performed using PubMed and a review of current urology, oncology, radiology and pathology journals. RESULTS: The incidence of adrenocortical tumors has been reported to be approximately 2/1 x 10(6) population, although this value may be an underestimate due to an increase in the incidence of unexpected adrenal masses or incidentalomas in the last decade. There has been a bimodal age incidence of adrenal carcinoma with most patients 40 to 50 years old in the studies reviewed. Overall the prevalence of adrenal tumors was slightly higher in females with most presenting with Cushing's syndrome. Of the 602 adrenal tumors reviewed 62% were functional and 38% were nonfunctional. Modern day imaging, including ultrasound, computerized tomography (CT) and magnetic resonance imaging, have greatly improved the diagnosis and staging of adrenal carcinoma. Surgical removal of a localized tumor and absent metastatic disease were associated with improved survival. Medical therapy with mitotane and its successors in patients with metastatic disease appear to be of little benefit for improving survival. CONCLUSIONS: Based on a review of the literature we recommend that hormone levels should be determined in symptomatic and asymptomatic patients with adrenal masses. CT should be the first study done to define an adrenal mass. All solid incidentalomas greater than 5 cm. on CT or magnetic resonance imaging should be removed surgically. The best chance of survival was achieved by surgical extirpation with the value of adjuvant therapy yet to be determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 40% and 60% of ACCs are functional and may present with symptoms of hormonal hypersecretion (126,127,128,129), most commonly with Cushing’s syndrome (estimated 45%).”
From Adrenal incidentaloma (2020) · cites this paper as [127]
In the citing paper
“Feminization and hyperaldosteronism are rare occurring in <10% of cases (127,130).”
From Adrenal incidentaloma (2020) · cites this paper as [127]
In the citing paper
“Primary ACC is rare, with an estimated population incidence of 1 to 2 per million per year (126,127).”
From Adrenal incidentaloma (2020) · cites this paper as [127]
In the citing paper
“most commonly with Cushing’s syndrome (estimated 45%).”
From Adrenal incidentaloma (2020) · cites this paper as [127]
In the citing paper
“ACC is rare and aggressive and can occur at any age. However, peak incidence tends to be before the age of 5 and between the ages of 40 and 60 years of age (126,127).”
From Adrenal incidentaloma (2020) · cites this paper as [127]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920
Pathologic features of prognostic significance in adrenocortical carcinoma
Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198903000-00004 · Cited by 818
Orth, D. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321207 · Cited by 563
Hormonal Evaluation of the Patient with an Incidentally Discovered Adrenal Mass
Desforges, J. F., Ross, N. S., & Aron, D. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232007 · Cited by 337
An eleven-year experience with adrenocortical carcinoma.
Pommier, R. F., & Brennan, M. F. (1992) · PubMed · Cited by 332
Hough (1979) · doi:10.1093/ajcp/72.3.390 · Cited by 320
BERTAGNA, C., & Orth, D. N. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90384-3 · Cited by 245
Latronico, A. C., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3921 · Cited by 191
LAPAROSCOPIC ADRENALECTOMY: THE PREFERRED CHOICE? A COMPARISON TO OPEN ADRENALECTOMY
Winfield, H. N., Hamilton, B. D., Bravo, E. L., & Novick, A. C. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62884-2 · Cited by 175
Research works printed but not linked: 1
- Shapiro, 1990, Contributions of nuclear endocrinology to the diagnosis of adrenal tumors. Recent results, Cancer Res, 118, 113
Cited by
Sorted by citations
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Zeiger, M. A., Thompson, G. B., Duh, Q.-Y., Hamrahian, A. H., Angelos, P., Elaraj, D., Fishman, E., Kharlip, J., Zeiger, M. A., Thompson, G. B., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s1.1 · Cited by 499
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Feminization and hyperaldosteronism are rare occurring in <10% of cases (127,130).”
BackgroundInfluentialAdrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls
Johnson, P. T., Horton, K. M., & Fishman, E. K. (2009) · Radiographics · doi:10.1148/rg.295095027 · Cited by 238
Adrenocortical carcinoma: the range of appearances on CT and MRI
Bharwani, N., Rockall, A. G., Sahdev, A., Gueorguiev, M., Drake, W., Grossman, A. B., & Reznek, R. H. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.5540 · Cited by 215
Giovanni Lughezzani, A., Sun, M., Perrotte, P., Claudio Jeldres, A., Alasker, A., Hendrik Isbarn, A., Budäus, L., Shariat, S. F., Guazzoni, G. F., Montorsi, F., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.007 · Cited by 214
Kulke, M. H., Benson, A. B., Bergsland, E. K., Berlin, J. D., Blaszkowsky, L. S., Choti, M. A., Clark, O. H., Doherty, G. M., Eason, J., Emerson, L. L., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0075 · Cited by 195
Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma
Barlaskar, F. M., Spalding, A. C., Heaton, J. H., Kuick, R., Kim, A. C., Thomas, D. G., Giordano, T. J., Ben-Josef, E., & Hammer, G. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1456 · Cited by 189
The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study
Sharma, E., Dahal, S., Sharma, P., Bhandari, A., Gupta, V., Amgai, B., & Dahal, S. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3503w · Cited by 161
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
Pacák, K., Eisenhofer, G., & Goldstein, D. S. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0032 · Cited by 154
Imaging features of adrenal masses
Albano, D., Agnello, F., Midiri, F., Pecoraro, G., Bruno, A., Alongi, P., Toia, P., Buono, G. D., Agrusa, A., Sconfienza, L. M., et al. (2019) · Insights into Imaging · doi:10.1186/s13244-019-0688-8 · Cited by 144
Imaging Evaluation of the Inferior Vena Cava
Smillie, R. P., Shetty, M., Boyer, A. C., Madrazo, B. L., & Jafri, S. Z. H. (2015) · Radiographics · doi:10.1148/rg.352140136 · Cited by 129
Wnt/β-catenin signalling in adrenal physiology and tumour development
Berthon, A., Martinez, A., Bertherat, J., & Val, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.009 · Cited by 125
Cushing’s Syndrome in Pediatrics
Lodish, M. B., Keil, M. F., & Stratakis, C. A. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.008 · Cited by 167
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy
Thompson, R. H., Cheville, J. C., Lohse, C. M., Webster, W. S., Zincke, H., Kwon, E. D., Frank, I., Blute, M. L., & Leibovich, B. C. (2005) · Cancer · doi:10.1002/cncr.21125 · Cited by 115
Adrenal Imaging: A Comprehensive Review
Taffel, M. T., Haji-Momenian, S., Nikolaidis, P., & Miller, F. H. (2012) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2012.02.009 · Cited by 108
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K., Mastorakos, G. P., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 112
Partial Adrenalectomy: Underused First Line Therapy for Small Adrenal Tumors
Kaye, D. R., Storey, B., Pacák, K., Pinto, P. A., Linehan, W. M., & Bratslavsky, G. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.03.052 · Cited by 105
Johnson, P. T., Horton, K. M., & Fishman, E. K. (2009) · Radiographics · doi:10.1148/rg.295095026 · Cited by 95
Ichijo, T., Ueshiba, H., Nawata, H., & Yanase, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0486 · Cited by 97
Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications
Adam, S. Z., Nikolaidis, P., Horowitz, J. M., Gabriel, H. A., Hammond, N. A., Patel, T., Yaghmai, V., & Miller, F. H. (2016) · Radiographics · doi:10.1148/rg.2016150139 · Cited by 89
Yang, J. Y., Yang, M. Q., Luo, Z., Ma, Y., Li, J., Deng, Y., & Huang, X. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-s1-s23 · Cited by 88
A genetic and molecular update on adrenocortical causes of Cushing syndrome
Lodish, M. B., & Stratakis, C. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.24 · Cited by 88
The inferior vena cava: anatomical variants and acquired pathologies
Li, S. J., Lee, J., Hall, J., & Sutherland, T. (2021) · Insights into Imaging · doi:10.1186/s13244-021-01066-7 · Cited by 80
Adrenal incidentaloma: a diagnostic challenge
Anagnostis, P. G., Karagiannis, A. I., Τζιόμαλος, Κ., Kakafika, A. I., Athyros, V. G., & Mikhailidis, D. P. (2009) · HORMONES · doi:10.14310/horm.2002.1233 · Cited by 79
Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma
Sasano, H., Suzuki, T., & Moriya, T. (2006) · Endocrine Pathology · doi:10.1007/s12022-006-0006-0 · Cited by 69
Adrenocortical tumorigenesis: Lessons from genetics
Kamilaris, C. D. C., Hannah‐Shmouni, F., & Stratakis, C. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101428 · Cited by 71
Update on tumours of the adrenal cortex, phaeochromocytoma and extra‐adrenal paraganglioma
McNicol, A. M. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03613.x · Cited by 68
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
Hirschberg, A. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac673 · Cited by 62
Machine learning-based texture analysis for differentiation of large adrenal cortical tumours on CT
Elmohr, M. M., Fuentes, D., Habra, M. A., Bhosale, P., Qayyum, A., Gates, E. D. H., Morshid, A. I., Hazle, J. D., & Elsayes, K. M. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.06.021 · Cited by 60
The clinical significance of adrenal incidentalomas
Androulakis, I. I., Kaltsas, G., Piaditis, G. P., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02436.x · Cited by 61
Ahmed, A. A., Thomas, A. J., Ganeshan, D., Blair, K. J., Lall, C. G., Lee, J. T., Morshid, A. I., Habra, M. A., & Elsayes, K. M. (2020) · Abdominal Radiology · doi:10.1007/s00261-019-02371-y · Cited by 59
Low, G., Dhliwayo, H., & Lomas, D. J. (2012) · Clinical Radiology · doi:10.1016/j.crad.2012.02.005 · Cited by 58
CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses
Lumachi, F., Borsato, S., Tregnaghi, A., Basso, S. M. M., Marchesi, P., Ciarleglio, F. A., Fassina, A., & Favia, G. (2003) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(03)00159-8 · Cited by 56
Adrenal tumours are more predominant in females regardless of their histological subtype: a review
Audenet, F., Méjean, A., Chartier-Kastler, E. J., & Morgan Rouprêt, A. (2013) · World Journal of Urology · doi:10.1007/s00345-012-1011-1 · Cited by 59
Sant, H. P. V., Bouvy, N. D., Geert Kazemier, M., Bonjer, H. J., Hop, W. C. J., Feelders, R. A., de Herder, W. W., & de Krijger, R. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02747.x · Cited by 56
Outcomes after resection of cortisol-secreting adrenocortical carcinoma
Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., Phay, J. E., et al. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2015.09.020 · Cited by 55
Nakamura (2015) · doi:10.1016/j.ecl.2015.02.007 · Cited by 55
Cuevas, C. M., Raske, M. E., Bush, W. H., Τakayama, T. K., Maki, J. H., Kolokythas, O., & Meshberg, E. B. (2006) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2006.02.006 · Cited by 53
Impact of 18F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients
Takeuchi, S., Balachandran, A., Habra, M. A., Phan, A. T., Bassett, R. L., Macapinlac, H. A., & Chuang, H. H. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2834-3 · Cited by 54
Sutter, J. A., & Grimberg, A. (2006) · PubMed · Cited by 51
Adrenocortical cancer: recent clinical and molecular advances
Sidhu, S. B., Sywak, M. S., Robinson, B. G., & Delbridge, L. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00004 · Cited by 51
Strosberg, J. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.11.009 · Cited by 48
Vaughan, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00149-4 · Cited by 49
Pediatric adrenocortical carcinoma
Ilanchezhian, M., Varghese, D. G., Glod, J. W., Reilly, K. M., Widemann, B. C., Pommier, Y. G., Kaplan, R. N., & Rivero, J. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.961650 · Cited by 51
Adrenal Cortical Carcinoma—Review of Current Knowledge and Treatment Practices
Phan, A. T. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.007 · Cited by 45
Current and Emerging Therapies for Advanced Adrenocortical Carcinoma
Tacon, L. J., Prichard, R. S., Soon, P. S. H., Robinson, B. G., Clifton-Bligh, R. J., & Sidhu, S. B. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0270 · Cited by 42
Asare, E. A., Wang, T. S., Winchester, D. P., Mallin, K., Kebebew, E., & Sturgeon, C. (2014) · Surgery · doi:10.1016/j.surg.2014.08.018 · Cited by 45
Current Status and Future Targeted Therapy in Adrenocortical Cancer
Alyateem, G., & Nilubol, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.613248 · Cited by 42
An update on Cushing syndrome in pediatrics
Stratakis, C. A. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.010 · Cited by 51
THE IMPACT OF TUMOR STAGE ON PROGNOSIS IN CHILDREN WITH ADRENOCORTICAL CARCINOMA
Tucci, S., Martins, A. C. P., Suaid, H. J., Cologna, A. J., & dos Reis, R. B. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000180645.89054.fd · Cited by 42
Wagner, A. S., Fleitz, J. M., & Kleinschmidt-DeMasters, B. K. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-0376-z · Cited by 41
The inferior vena cava: a pictorial review of embryology, anatomy, pathology, and interventions
Shin, D. S., Sandstrom, C. K., Ingraham, C. R., Monroe, E. J., & Johnson, G. E. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01988-3 · Cited by 41
Vuorenoja, S., Rivero‐Müller, A., Kiiveri, S., Bielińska, M., Heikinheimo, M., Wilson, D. B., Huhtaniemi, I. T., & Rahman, N. A. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.11.013 · Cited by 41
Potent Inhibitory Effects of Type I Interferons on Human Adrenocortical Carcinoma Cell Growth
van Koetsveld, P. M., Vitale, G., de Herder, W. W., Feelders, R. A., van der Wansem, K., Waaijers, M., van Eijck, C. H. J., Speel, E. M., Croze, E., van der Lely, A. J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0620 · Cited by 41
Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
Hirschberg, A. L. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad590 · Cited by 44
Practical Approach to Adrenal Imaging
Elsayes, K. M., Emad‐Eldin, S., Morani, A. C., & Jensen, C. T. (2016) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2016.10.005 · Cited by 36
Genetics of Adrenocortical Development and Tumors
Lodish, M. B. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.007 · Cited by 37
Adrenocortical carcinosarcoma: a case report and review of the literature
Sasaki, K., Desimone, M. E., Rao, H. R., Huang, G. J., & Seethala, R. R. (2010) · Diagnostic Pathology · doi:10.1186/1746-1596-5-51 · Cited by 36
Adrenal Lesions: A Review of Imaging
Bracci, B., Santis, D. D., Gaudio, A. D., Faugno, M. C., Romano, A., Tarallo, M., Zerunian, M., Guido, G., Polici, M., Polidori, T., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12092171 · Cited by 34
Fine-Needle Aspiration of Adrenal Cortical Carcinoma
Ren, R., Guo, M., Sneige, N., Moran, C. A., & Gong, Y. (2006) · American Journal of Clinical Pathology · doi:10.1309/aqfeb5wemu41n9k1 · Cited by 34
Pinto, E. M., Morton, C. L., Galindo, C. R., McGregor, L. M., Davidoff, A. M., Mercer, K., Debelenko, L. V., Billups, C. A., Ribeiro, R. C., & Zambetti, G. P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3354 · Cited by 33
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31
Dickson, P. V., Kim, L., Yen, T. W. F., Yang, A. D., Grubbs, E. G., Patel, D., & Solórzano, C. C. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6749-2 · Cited by 32
Liu, J., Li, X.-D., Vaheri, A. I., & Voutilainen, R. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01560 · Cited by 34
Aldosterone-Secreting Adrenal Cortical Carcinoma. A Case Report and Review of the Literature
Griffin, A. C., Kelz, R. K., & LiVolsi, V. A. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9307-x · Cited by 31
Experience with the surgical treatment of adrenal cortical carcinoma
Meyer, A. A., Niemann, U., & Behrend, M. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.01.021 · Cited by 30
Kutikov, A., Mallin, K., Canter, D. J., Wong, Y., & Uzzo, R. G. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.072 · Cited by 30
Adrenal Cavernous Hemangioma: A Case Report with Review of the Literature
Noh, J. J., Choi, S. H., Hwang, H. K., Kang, C. M., & Lee, W. J. (2014) · PubMed · doi:10.6092/1590-8577/2402 · Cited by 29
Eki̇ci̇, S., & Ciancio, G. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000143931.26872.43 · Cited by 28
The next generation of therapies for adrenocortical cancers
Kirschner, L. S. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.001 · Cited by 27
Histopathological Diagnosis and Prognostic Factors in Adrenocortical Carcinoma
Aiba, M., & Fujibayashi, M. (2005) · Endocrine Pathology · doi:10.1385/ep:16:1:013 · Cited by 27
Korah, R. M., Healy, J. M., Kunstman, J. W., Fonseca, A. L., Ameri, A. H., Prasad, M. L., & Carling, T. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-87 · Cited by 26
Reginelli, A., Vacca, G., Belfiore, M. P., Sangiovanni, A., Nardone, V., Vanzulli, A., Grassi, R., & Cappabianca, S. (2020) · Gland Surgery · doi:10.21037/gs-20-559 · Cited by 26
Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis: Causes and Imaging Findings
Olson, M. C., Lubner, M. G., Menias, C. O., Mellnick, V. M., Gettle, L. M., Kim, D. H., Elsayes, K. M., & Pickhardt, P. J. (2020) · Radiographics · doi:10.1148/rg.2020190097 · Cited by 25
Clinical and imaging overview of functional adrenal neoplasms
Low, G., & Sahi, K. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.03014.x · Cited by 25
Adrenocortical carcinoma presenting as varicocele and renal vein thrombosis: a case report
Cheungpasitporn, W., Horne, J. M., & Howarth, C. B. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-337 · Cited by 24
Suzuki, S., Minamidate, T., Shiga, A., Ruike, Y., Ishiwata, K., Naito, K., Ishida, A., Deguchi, H., Fujimoto, M., Koide, H., et al. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00652-y · Cited by 26
Khan, M. A., Caoili, E. M., Davenport, M. S., Poznanski, A., Francis, I. R., Giordano, T. J., & Dunnick, N. R. (2013) · Abdominal Imaging · doi:10.1007/s00261-013-0047-z · Cited by 23
Adrenal-sparing surgery: current concepts on a theme from the past
Perysinakis, I., Aggeli, C., Kaltsas, G., & Zografos, G. N. (2020) · HORMONES · doi:10.1007/s42000-020-00202-0 · Cited by 23
Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma
Clay, M. R., Pinto, E. M., Fishbein, L. M., Else, T., & Kiseljak‐Vassiliades, K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab866 · Cited by 24
Survival and prognostic factors for adrenocortical carcinoma: a single institution experience
Loncar, Z. M., Djukić, V., Zivaljevic, V. R., Pekmezovic, T. D., Diklić, A., Tatic, S. B., Dundjerović, D., Oluić, B., Slijepčević, N., & Paunovic, I. R. (2015) · BMC Urology · doi:10.1186/s12894-015-0038-1 · Cited by 22
Surgical Management of Adrenocortical Carcinoma
Ranvier, G. G. F., & Inabnet, W. B. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.008 · Cited by 22
de Melo-Leite, A. F., Elias, P. C. L., Teixeira, S. R., Tucci, S., Barros, G. E., Antonini, S. R. R., Muglia, V. F., & Elías, J. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0080 · Cited by 22
DeLozier, O. M., Stiles, Z. E., Deschner, B. W., Drake, J. A., Deneve, J. L., Glazer, E. S., Tsao, M. W., Yakoub, D., & Dickson, P. V. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08824-9 · Cited by 23
Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion
LeGout, J. D., Bailey, R. E., Bolan, C. W., Bowman, A. W., Chen, F., Cernigliaro, J. G., & Alexander, L. F. (2020) · Radiographics · doi:10.1148/rg.2020200047 · Cited by 22
Adrenocortical carcinoma with fat inclusion: case report
Heye, S., Woestenborghs, H., Kerkhove, F. V., & Oyen, R. (2005) · Abdominal Imaging · doi:10.1007/s00261-004-0281-5 · Cited by 22
Sömjen, D., Stern, N., Knoll, E., Sharon, O., Gayer, B., Kulik, T., & Kohen, F. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790395 · Cited by 22
Feminizing Adrenal Neoplasms: Case Presentations and Review of the Literature
Kidd, M. T., Karlin, N. J., & Cook, C. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4799 · Cited by 21
The Immunotherapy Landscape in Adrenocortical Cancer
Pegna, G. J., Roper, N., Kaplan, R. N., Bergsland, E. K., Kiseljak‐Vassiliades, K., Habra, M. A., Pommier, Y. G., & Rivero, J. D. (2021) · Cancers · doi:10.3390/cancers13112660 · Cited by 22
A Multimodality Review of Adrenal Tumors
Bhargava, P., Sangster, G. P., Haque, K., Garrett, J. D., Donato, M., & D'Agostino, H. R. (2018) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2018.10.002 · Cited by 20
Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinoma
Pacella, C. M., Stasi, R., Bizzarri, G., Pacella, S., Graziano, F. M., Guglielmi, R., & Papini, E. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.04.009 · Cited by 20
Childhood adrenocortical carcinoma: Case report and review
Mk, G., Gundgurthi, A., Kharb, S., Dutta, M., Khare, A., Jacob, M., & Bhardwaj, R. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.95699 · Cited by 20
Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism
Steichen, O., Lorthioir, A., Zinzindohoué, F., Plouin, P., & Amar, L. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.10.003 · Cited by 20
Practical Approach to Adrenal Imaging
Elsayes, K. M., Emad‐Eldin, S., Morani, A. C., & Jensen, C. T. (2018) · Urologic Clinics of North America · doi:10.1016/j.ucl.2018.03.005 · Cited by 19
Metastatic Adrenocortical Carcinoma: a Single Institutional Experience
Owen, D. H., Patel, S. H., Wei, L., Phay, J. E., Shirley, L. A., Kirschner, L. S., Schmidt, C. R., Abdel‐Misih, S., Brock, P. L., Shah, M. H., et al. (2019) · Hormones and Cancer · doi:10.1007/s12672-019-00367-0 · Cited by 20
Knott, E. L., & Leidenheimer, N. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228485 · Cited by 19
Minowada, S., Fujimura, T., Takahashi, N., Kishi, H., Hasuo, K., & Minami, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030530 · Cited by 19
The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
Balajam, N. Z., Mousavian, A.-H., Sheidaei, A., Gohari, K., Tavangar, S. M., Ghanbari, A., Ostovar, A., Shafiee, G., & Heshmat, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-34155-2 · Cited by 18
Metadata
- Authors
- NG, L., & LIBERTINO, J. M.
- Affiliations
- Lahey Hospital and Medical Center (US)
- Venue
- Journal of Urology
- Published
- 2003-01
- Volume
- 169
- Issue
- 1
- Pages
- 5-11
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2105268776
- Cited by
- 423
- References
- 37
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 22 · 2020: 21 · 2019: 22 · 2018: 13 · 2017: 14 · 2016: 24 · 2015: 28 · 2014: 24 · 2013: 13 · 2012: 25
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Urology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenal tumors, Cushing's syndrome, adrenal incidentaloma, functional adrenal tumors, adrenal imaging, computed tomography, magnetic resonance imaging, mitotane, adjuvant therapy, surgical resection, prognosis
- MeSH terms
- Adrenal Cortex Neoplasms, Humans, Prognosis, Adrenocortical Carcinoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review